Skip Nav Destination
Article navigation
Letters|
October 01 1993
Intraperitoneal Insulin Affects Insulin-Like Growth Factor Binding Protein-1 in a Well-Controlled Type I Diabetic Patient
Kathleen D Hopkins, MD;
Kathleen D Hopkins, MD
Department of Endocrinology and Chemical Pathology, UMDS, St. Thomas' Hospital
London, United Kingdom
Search for other works by this author on:
David L Russell-Jones, MRCP;
David L Russell-Jones, MRCP
Department of Endocrinology and Chemical Pathology, UMDS, St. Thomas' Hospital
London, United Kingdom
Search for other works by this author on:
Eldon D Lehmann, BSC;
Eldon D Lehmann, BSC
Department of Endocrinology and Chemical Pathology, UMDS, St. Thomas' Hospital
London, United Kingdom
Search for other works by this author on:
Michael J Wheeler, PHD;
Michael J Wheeler, PHD
Department of Endocrinology and Chemical Pathology, UMDS, St. Thomas' Hospital
London, United Kingdom
Search for other works by this author on:
Peter H Sönksen, FRCP
Peter H Sönksen, FRCP
Department of Endocrinology and Chemical Pathology, UMDS, St. Thomas' Hospital
London, United Kingdom
Search for other works by this author on:
Address correspondence to Kathleen D. Hopkins, MD, Division of Medicine, Fourth Floor, North Wing, St. Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, U.K.
Diabetes Care 1993;16(10):1404–1405
Citation
Kathleen D Hopkins, David L Russell-Jones, Eldon D Lehmann, Michael J Wheeler, Peter H Sönksen; Intraperitoneal Insulin Affects Insulin-Like Growth Factor Binding Protein-1 in a Well-Controlled Type I Diabetic Patient. Diabetes Care 1 October 1993; 16 (10): 1404–1405. https://doi.org/10.2337/diacare.16.10.1404
Download citation file: